Ulhas R Dhuppad,Sunil Chaudhari,Suresh Rajurkar,Nilesh Jain,Chandrakant Dhatrak,Alkesh Kasliwal
申请号：
US16527817
公开号：
US20200197370A1
申请日:
2019.07.31
申请国别(地区):
US
年份:
2020
代理人:
摘要：
The present invention relates to a nanoparticulate formulation comprising a microsomal prostaglandin E synthases-1 (“mPGES-1”) inhibitor. Particularly, the present invention relates to a nanoparticulate formulation comprising an mPGES-1 inhibitor and one or more surface stabilizers； a process for preparing such formulation； and its use in treating pain and inflammation in a subject.
